PTC Therapeutics PTCT
$ 40.92
1.3%
Quarterly report 2024-Q2
added 08-08-2024
PTC Therapeutics Balance Sheet 2011-2024 | PTCT
Annual Balance Sheet PTC Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-297 M | 301 M | 91.9 M | 100 M | 25.8 M | -16.5 M | 113 M | 213 M | 317 M | -49.7 M | -15.4 M | 2.16 M | -16.7 M |
Long Term Debt |
284 M | 572 M | 282 M | 309 M | 294 M | 141 M | 145 M | 98.2 M | 94.6 M | - | - | 439 K | 4.55 M |
Long Term Debt Current |
13 M | 9.37 M | 7.27 M | 7.46 M | 5.15 M | 11.7 M | - | - | - | - | 48.6 K | - | - |
Total Non Current Liabilities |
- | - | - | - | 794 M | 602 M | 153 M | 100 M | 96.7 M | 2.28 M | 2.23 M | 4.11 M | 240 M |
Total Current Liabilities |
603 M | 406 M | 509 M | 277 M | 236 M | 167 M | 82 M | 49.6 M | 45.4 M | 32.5 M | 13.1 M | - | - |
Total Liabilities |
2.71 B | 2.05 B | 1.94 B | 1.73 B | 1.03 B | 768 M | 235 M | 150 M | 142 M | 34.8 M | 15.4 M | 32.3 M | 283 M |
Deferred Revenue |
801 K | 1.35 M | - | 4.15 M | 8.24 M | 3.72 M | 3.94 M | - | 139 K | 3.35 M | 877 K | 16.7 M | 23 M |
Retained Earnings |
-3.28 B | -2.66 B | -2.1 B | -1.63 B | -1.19 B | -939 M | -814 M | -735 M | -593 M | -423 M | -329 M | -277 M | -251 M |
Total Assets |
1.9 B | 1.71 B | 1.94 B | 2.21 B | 1.62 B | 1.12 B | 392 M | 269 M | 368 M | 333 M | 152 M | 13.1 M | 44.1 M |
Cash and Cash Equivalents |
594 M | 280 M | 197 M | 216 M | 288 M | 169 M | 112 M | 58.3 M | 58 M | 49.7 M | 15.4 M | 2.73 M | 28.4 M |
Book Value |
-819 M | -347 M | 1.44 M | 482 M | 594 M | 351 M | 156 M | 120 M | 226 M | 298 M | 137 M | -19.2 M | -239 M |
Total Shareholders Equity |
-819 M | -347 M | 1.44 M | 482 M | 594 M | 351 M | 156 M | 120 M | 226 M | 298 M | 137 M | -99.6 M | -239 M |
All numbers in USD currency
Quarterly Balance Sheet PTC Therapeutics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
285 M | 285 M | 284 M | 573 M | 573 M | 572 M | 572 M | 283 M | - | 282 M | 282 M | 282 M | 430 M | 430 M | 309 M | 309 M | 309 M | 309 M | 294 M | 294 M | 294 M | 294 M | 141 M | 141 M | 141 M | 141 M | 145 M | 145 M | 145 M | 145 M | 98.2 M | 98.2 M | 98.2 M | 98.2 M | 91.8 M | 91.8 M | 91.8 M | 91.8 M | - | - | - | - | - | - | - | - | 439 K | 439 K | 439 K | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.9 B | 2.68 B | 2.71 B | 1.93 B | 1.92 B | 2.07 B | 2.05 B | 1.8 B | - | 1.89 B | 1.94 B | 1.9 B | 1.86 B | 1.82 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 1.03 B | 1.03 B | 1.03 B | 1.03 B | 768 M | 768 M | 768 M | 768 M | 235 M | 235 M | 235 M | 235 M | 150 M | 150 M | 150 M | 150 M | 139 M | 139 M | 139 M | 139 M | 34.8 M | 34.8 M | 34.8 M | 34.8 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 31.9 M | 31.9 M | 31.9 M | - | - | - | - | - |
Deferred Revenue |
- | - | 801 K | 1.22 M | - | 214 K | 1.35 M | - | - | - | - | - | - | 1.89 M | 4.15 M | 4.15 M | 4.15 M | 4.15 M | 8.24 M | 8.24 M | 8.24 M | 8.24 M | 3.72 M | 3.72 M | 3.72 M | - | 3.94 M | 6.12 M | 2.6 M | - | - | - | - | 396 K | 139 K | 139 K | 139 K | 139 K | 3.35 M | 3.35 M | 3.35 M | 3.35 M | 878 K | 878 K | 878 K | 878 K | 16.7 M | 16.7 M | 16.7 M | - | - | - | - | - |
Retained Earnings |
-3.47 B | -3.38 B | -3.28 B | -3.13 B | -2.99 B | -2.8 B | -2.66 B | -2.49 B | - | -2.22 B | -2.1 B | -1.95 B | -1.82 B | -1.7 B | -1.63 B | -1.63 B | -1.63 B | -1.63 B | -1.19 B | -1.19 B | -1.19 B | -1.19 B | -939 M | -939 M | -939 M | -939 M | -814 M | -814 M | -814 M | -814 M | -735 M | -735 M | -735 M | -735 M | -593 M | -593 M | -593 M | -593 M | -423 M | -423 M | -423 M | -423 M | -329 M | -329 M | -329 M | -329 M | -277 M | -277 M | -277 M | - | - | - | - | - |
Total Assets |
1.92 B | 1.79 B | 1.9 B | 1.26 B | 1.34 B | 1.61 B | 1.71 B | 1.58 B | - | 1.8 B | 1.94 B | 2.01 B | 2.06 B | 2.11 B | 2.21 B | 2.21 B | 2.21 B | 2.21 B | 1.62 B | 1.62 B | 1.62 B | 1.62 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 392 M | 392 M | 392 M | 392 M | 269 M | 269 M | 269 M | 269 M | 365 M | 365 M | 365 M | 365 M | 333 M | 333 M | 333 M | 333 M | 152 M | 152 M | 152 M | 152 M | 13.1 M | 13.1 M | 13.1 M | - | - | - | - | - |
Cash and Cash Equivalents |
655 M | 548 M | 594 M | 165 M | 224 M | 234 M | 280 M | 121 M | 174 M | 152 M | 190 M | 197 M | 177 M | 147 M | 209 M | 209 M | 209 M | 209 M | 288 M | 288 M | 288 M | 288 M | 169 M | 169 M | 169 M | 169 M | 112 M | 112 M | 112 M | 112 M | 58.3 M | 58.3 M | 58.3 M | 58.3 M | 58 M | 58 M | 58 M | 58 M | 49.7 M | 49.7 M | 49.7 M | 49.7 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 2.73 M | 2.73 M | 2.73 M | - | 28.4 M | - | - | - |
Book Value |
-980 M | -894 M | -819 M | -671 M | -579 M | -458 M | -347 M | -227 M | - | -90.6 M | 1.44 M | 105 M | 197 M | 293 M | 482 M | 482 M | 482 M | 482 M | 594 M | 594 M | 594 M | 594 M | 351 M | 351 M | 351 M | 351 M | 156 M | 156 M | 156 M | 156 M | 120 M | 120 M | 120 M | 120 M | 226 M | 226 M | 226 M | 226 M | 298 M | 298 M | 298 M | 298 M | 137 M | 137 M | 137 M | 137 M | -18.8 M | -18.8 M | -18.8 M | - | - | - | - | - |
Total Shareholders Equity |
-980 M | -894 M | -819 M | -671 M | -579 M | -458 M | -347 M | -227 M | -182 M | -90.6 M | 1.44 M | 105 M | 197 M | 293 M | 482 M | 482 M | 482 M | 482 M | 594 M | 594 M | 594 M | 594 M | 351 M | 351 M | 351 M | 351 M | 156 M | 156 M | 156 M | 156 M | 120 M | 120 M | 120 M | 120 M | 226 M | 226 M | 226 M | 226 M | 298 M | 298 M | 298 M | 298 M | 137 M | 137 M | 137 M | 137 M | -99.6 M | -99.6 M | -99.6 M | - | -239 M | - | - | - |
All numbers in USD currency